Publications by authors named "Hilke Zander"

Claim this Profile
M
Multistakeholder scientific advice for medicinal products used in combination with a medical device or a companion diagnostic in the EU-summary of a Focus group discussion.
Stiina Aarum, Claudia Popp, Alexa Hunter, Miha Skvarc, Ilona Reischl, Hilke Zander

Front Med (Lausanne)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2024 White paper on recent issues in bioanalysis: Impact of LDT in US and IVDR in EU; AI/ML for High Parameter Flow Cytometry; The rise of Olink Technology; CDx for AAV Gene Therapies; Integrative Bioanalysis by Multiple Platforms; Super Sensitive ADA/NAb LBA ( - Recommendations on Advanced Strategies for Biomarkers, IVD/CDx Assays (BAV), Cell Based Assays (CBA), and Ligand-Binding Assays (LBA) - Regulatory Agencies' Input on Biomarkers, IVD/CDx, and Biomarker Assay Validation).
Nicoletta Bivi, Danielle Graham, Laura Joglekar, Kristina McGuire, Jeroen Stoop, Hilke Zander

Bioanalysis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histology independent drug development - Is this the future for cancer drugs?
Lucinda Billingham, Lynn Brown, Theodor Framke, Alastair Greystoke, Eivind Hovig, Hilke Zander

Cancer Treat Rev· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker-Driven Developments in the Context of the New Regulatory Framework for Companion Diagnostics in the European Union.
Ciska Verbaanderd, Ana Trullás Jimeno, Jörg Engelbergs, Hilke Zander, Ilona Reischl

Clin Pharmacol Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Checkpoint inhibitors for cancer therapy].
Hilke Zander, Susanne Müller-Egert, Michal Zwiewka, Steffen Groß, Ger van Zandbergen

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenascin-C serum levels and its prognostic power in non-small cell lung cancer.
Florian Gebauer, Suyin Gelis, Hilke Zander, Karl-Frederick Meyer, Gerrit Wolters-Eisfeld

Oncotarget· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated leukocyte cell adhesion molecule (CD166): an "inert" cancer stem cell marker for non-small cell lung cancer?
Michael Tachezy, Hilke Zander, Gerrit Wolters-Eisfeld, Julia Müller, Daniel Wicklein

Stem Cells· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR7 expression in esophageal cancer.
Michael Tachezy, Hilke Zander, Florian Gebauer, Katharina von Loga, Klaus Pantel

J Transl Med· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALCAM (CD166) expression and serum levels in pancreatic cancer.
Michael Tachezy, Hilke Zander, Andreas H Marx, Phillip R Stahl, Florian Gebauer

PLoS One· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.
Isabell Witzel, Christine Schröder, Volkmar Müller, Hilke Zander, Michael Tachezy

Oncology· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.
Michael Tachezy, Hilke Zander, Florian Gebauer, Andreas Marx, Jussuf T Kaifi

J Surg Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients.
Michael Tachezy, Katharina Effenberger, Hilke Zander, Sarah Minner, Florian Gebauer

Int J Cancer· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L1 is highly expressed in tumors of the nervous system: a study of over 8000 human tissues.
Tamina Rawnaq, Alexander Quaas, Hilke Zander, Stephanie J Gros, Uta Reichelt

J Surg Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.
Maike Ihnen, Kerstin Kress, Jan Felix Kersten, Ergin Kilic, Matthias Choschzick, Hilke Zander

BMC Cancer· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.
Michael Tachezy, Hilke Zander, Andreas H Marx, Florian Gebauer, Tamina Rawnaq

J Surg Res· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma.
Florian Gebauer, Michael Tachezy, Katharina Effenberger, Katharina von Loga, Hilke Zander

J Surg Oncol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer.
Cenap Güngör, Hilke Zander, Katharina E Effenberger, Yogesh K Vashist, Tatyana Kalinina

Cancer Res· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients.
Hilke Zander, Tamina Rawnaq, Max von Wedemeyer, Michael Tachezy, Miriam Kunkel

BMC Cancer· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum midkine correlates with tumor progression and imatinib response in gastrointestinal stromal tumors.
Tamina Rawnaq, Miriam Kunkel, Kai Bachmann, Ronald Simon, Hilke Zander

Ann Surg Oncol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epitope mapping of the neuronal growth inhibitor Nogo-A for the Nogo receptor and the cognate monoclonal antibody IN-1 by means of the SPOT technique.
Hilke Zander, Ulrich Reineke, Jens Schneider-Mergener, Arne Skerra

J Mol Recognit· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical characterization of the recombinant human Nogo-A ectodomain.
Hilke Zander, Eva Hettich, Kathrin Greiff, Lorenz Chatwell, Arne Skerra

FEBS J· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein.
Constanze Breithaupt, Anna Schubart, Hilke Zander, Arne Skerra, Robert Huber

Proc Natl Acad Sci U S A· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis